PHAXIAM Therapeutics S.A. Current Value Added Tax Receivables
PHAXIAM Therapeutics S.A. had Current Value Added Tax Receivables of EUR 899.00 thousand as of 2022-12-31, per its 20-F filed 2023-03-28.
Discontinued › Notes › Receivables
ifrs-full:CurrentValueAddedTaxReceivables · last filed 2023-03-28
- 2022-12-31: Current Value Added Tax Receivables 899.00K EUR.
- 2021-12-31: Current Value Added Tax Receivables 610.00K EUR.
- 2020-12-31: Current Value Added Tax Receivables 635.00K EUR.
- 2019-12-31: Current Value Added Tax Receivables 942.00K EUR.
| Period end | Current Value Added Tax Receivables |
|---|---|
| 2022-12-31 | 899.00K EUR 20-F · filed 2023-03-28 |
| 2021-12-31 | 610.00K EUR 20-F · filed 2023-03-28 |
| 2020-12-31 | 635.00K EUR 20-F · filed 2023-03-28 |
| 2019-12-31 | 942.00K EUR 20-F · filed 2022-04-27 |
| 2018-12-31 | 949.00K EUR 20-F · filed 2021-03-08 |
| 2017-12-31 | 1.02M EUR 20-F · filed 2020-03-18 |